Table 3.

Major Peripheral Blood Cell Counts 10 Days After 9 Gy TBI (3 × 3 Gy, 24 Hours Apart) and IP TPO Administration

Time Relative to TBI TPO Dose (μg) nRed Blood Cells (×1012/L) White Blood Cells (×109/L) Platelets (×109/L)
—  —  9  5.8 ± 0.8 0.26 ± 0.05  51 ± 25  
3× + 2h  0.3  8.6 ± 0.2* 0.93 ± 0.23* 883 ± 163* 
+2h 0.9  3  6.6 ± 0.7  0.43 ± 0.06* 527 ± 135* 
−2h  0.9  3  7.2 ± 0.2* 0.47 ± 0.06*, 215 ± 80*, 
−2h  30.0  3  8.4 ± 1.0* 0.90 ± 0.10* 792 ± 157* 
Normal mice  — 19  10.2 ± 0.6  5.3 ± 1.9  1,123 ± 89 
Time Relative to TBI TPO Dose (μg) nRed Blood Cells (×1012/L) White Blood Cells (×109/L) Platelets (×109/L)
—  —  9  5.8 ± 0.8 0.26 ± 0.05  51 ± 25  
3× + 2h  0.3  8.6 ± 0.2* 0.93 ± 0.23* 883 ± 163* 
+2h 0.9  3  6.6 ± 0.7  0.43 ± 0.06* 527 ± 135* 
−2h  0.9  3  7.2 ± 0.2* 0.47 ± 0.06*, 215 ± 80*, 
−2h  30.0  3  8.4 ± 1.0* 0.90 ± 0.10* 792 ± 157* 
Normal mice  — 19  10.2 ± 0.6  5.3 ± 1.9  1,123 ± 89 

3× + 2h, three doses of 0.3 μg TPO 2 hours after each dose of TBI; +2h, 0.9 μg TPO 2 hours after the last dose of TBI; −2h, 0.9 or 30 μg TPO 2 hours before the first dose of TBI.

*

Significantly different from control mice.

Significantly different from mice treated with 30 μg TPO 2 hours before TBI.

or Create an Account

Close Modal
Close Modal